In EVOKE and EVOKE+, oral semaglutide lowered several cerebrospinal-fluid markers of Alzheimers pathology, including phosphorylated tau and total tau, by up to roughly 10%, yet produced no measurable slowing of clinical decline
Other than that, low vitamin B12 levels are more common in those who are: Older than 65 years of age
Phosphono analogues of glutathione as new inhibitors of glutathione S-transferases
Maintaining high glutathione levels is associated with longevity and healthy aging
GLP-1 demand is driving nearly all growth, with Mounjaro at $8.7B (+125% YoY) and Zepbound at $4.1B (+80% YoY), reshaping Lillys revenue mix in real time
If lowering your dose does not resolve issues, professional evaluation helps rule out other causes and determine if continuing is appropriate